Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 187
News
News | 04 October 2021

Pfizer transfers certain medicines to Mylan as part of an agreement

The consideration for the medicines in India is valued at Rs 180.48 crore

News
News | 04 October 2021

Thermo Fisher opens biologics site in Lengnau, Switzerland

The state-of-the-art facility provides a pathway from development to large-scale biologics production

News
News | 01 October 2021

Veeda Clinical Research files DRHP for Rs 831 crore IPO

The issue will consist of the issuance of fresh equity shares worth up to Rs 331.60 crore and an offer for sale (OFS) of Rs 500 crore by promoters and existing shareholders

News
News | 01 October 2021

Global Health files DRHP for over Rs 500 crore issue

Global Health operates a network of four hospitals under the Medanta brand in Gurugram, Indore, Ranchi and Lucknow. In addition, one hospital is under construction in Patna, and another is planned for development in Noida

News
News | 01 October 2021

Merck to acquire Acceleron for US $ 11.5 billion

The acquisition complements and strengthens Merck’s cardiovascular pipeline

News
News | 28 September 2021

Cardiovascular devices market to grow at a CAGR of 3.9 % up to 2027

One of the key factors driving the market growth is the rise in the occurrence of chronic cardiovascular diseases such as heart failure and coronary artery disease: Valuates Reports

News
News | 28 September 2021

Zymo Research donates one million Covid-19 test kits to Mapmygenome

Its DirectDetect reagent eliminates RNA extraction for rapid deployment of Covid-19 tests in affected countries

News
News | 28 September 2021

Bal Pharma ramps up API capacity of Gliclazide

In terms of volume, the company commands a market share 25 per cent globally for Gliclazide, as per the IQVIA report

News
News | 26 September 2021

Cadila Healthcare signs agreement with Shilpa Medicare for production of ZyCoV-D

ZyCoV-D is the first DNA plasmid vaccine in the world for human use, developed indigenously by the company against the Covid-19 virus

News
News | 24 September 2021

Novavax and Serum seek WHO approval for Covid-19 vaccine

It is a recombinant nanoparticle protein-based vaccine

News
News | 24 September 2021

Lancet publishes NanoFlu vaccine Phase 3 trial results

The pivotal Phase 3 trial achieved all primary endpoints, demonstrating non-inferiority to a leading U.S.-licensed quadrivalent influenza vaccine

News
News | 24 September 2021

Amaris Clinicals clears U.S. FDA audit

The company is the Clinical Research Organisation of Caplin Point Laboratories

News
News | 23 September 2021

Indian Pharma Market growth stable in August 2021

Post normalisation of high growth months of April and May this year the average IPM growth from June to August this year stood at 15.2 % YoY : Ind-Ra reports

News
News | 22 September 2021

Kotak Mahindra offers financing options for healthcare

The bank will provide a complete range of financing options including hospitals, labs, diagnostic centres and equipment manufacturers

News
News | 21 September 2021

Zydus agrees to sell Mifegest and Cytolog to Integrace

The purchaser is a part of the portfolio companies of PE firm True North. The said transaction is not a related party transaction.

News
News | 20 September 2021

U.S. FDA concludes inspection of Lupin’s Goa facility with seven observations

The company said in a regulatory filing that it was confident of addressing the observations satisfactorily

News
News | 18 September 2021

India extends concession on life-saving Covid-19 drugs till December 2021

The council has also reduced the GST to 5 per cent on a few more Covid-19 medicines

News
News | 17 September 2021

QCI institutes Prof. SK Joshi laboratory excellence award

This award is open to all currently operational laboratories pertaining to testing, calibration & medical including their proficiency testing providers & reference material producers located in India

News
News | 17 September 2021

Promising prospects for Indian pharma: CLSA

CLSA, a capital market and investment group organised an Investors’ Forum where five Indian pharma companies participated. Excerpts from the report

News
News | 17 September 2021

Pharma exports for August 2021 at Rs 14,871 crores

In the period April to August 2021, exports stood at Rs 73,469.29 crores compared to Rs 72,275.22 crores for the period April to August 2020 a growth of 1.65 per cent

Startup

Digitization